Carriage prevalence,serotype distribution,and antimicrobial susceptibility among pneumococcal isolates recovered from adults with systemic lupus erythematosus
Restricted accessLetterFirst published online October, 2021
Carriage prevalence,serotype distribution,and antimicrobial susceptibility among pneumococcal isolates recovered from adults with systemic lupus erythematosus
FurerVRondaanCHeijstekMW, et al. 2019 Update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis2020; 79: 39–52.
2.
SimellBAuranenKKäyhtyHGoldblattDDaganRO’BrienKL; Pneumococcal Carriage Group.The fundamental link between pneumococcal carriage and disease. Expert Rev Vaccines2012; 11: 841–855.
3.
BoschAATMvan HoutenMABruinJP, et al. Nasopharyngeal carriage of Streptococcus pneumoniae and other bacteria in the 7th year after implementation of the pneumococcal conjugate vaccine in The Netherlands. Vaccine2016; 34: 531–539.
4.
SouthernJAndrewsNSanduP, et al. Pneumococcal carriage in children and their household contacts six years after introduction of the 13-valent pneumococcal conjugate vaccine in England. PLoS One2018; 13: e0195799.
5.
NevesFPPintoTCCorreaMA, et al. Nasopharyngeal carriage, serotype distribution and antimicrobial resistance of Streptococcus pneumoniae among children from Brazil before the introduction of the 10-valent conjugate vaccine. BMC Infect Dis2013; 13: 318.
6.
Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. 30th ed. CLSI supplement M100. Wayne, PA: CLSI, 2020.
7.
Centers for Disease Control and Prevention. Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the advisory committee on immunization practices (ACIP). MMWR Morb Mortal Wkly Rep2012; 61: 816–819.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
